NYSE:EHC Encompass Health (EHC) Stock Price, News & Analysis $113.33 +11.92 (+11.75%) Closing price 04/25/2025 03:59 PM EasternExtended Trading$113.09 -0.24 (-0.21%) As of 04/25/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Encompass Health Stock (NYSE:EHC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Encompass Health alerts:Sign Up Key Stats Today's Range$108.25▼$114.3850-Day Range$93.57▼$113.3352-Week Range$82.09▼$114.38Volume2.08 million shsAverage Volume675,826 shsMarket Capitalization$11.41 billionP/E Ratio25.41Dividend Yield0.60%Price Target$113.14Consensus RatingBuy Company OverviewEncompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.Read More… Encompass Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks77th Percentile Overall ScoreEHC MarketRank™: Encompass Health scored higher than 77% of companies evaluated by MarketBeat, and ranked 148th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.6 / 5Analyst RatingBuy Consensus RatingEncompass Health has received a consensus rating of Buy. The company's average rating score is 3.11, and is based on 8 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageEncompass Health has only been the subject of 4 research reports in the past 90 days.Read more about Encompass Health's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth10.00% Earnings GrowthEarnings for Encompass Health are expected to grow by 10.00% in the coming year, from $4.80 to $5.28 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Encompass Health is 25.41, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.67.Price to Earnings Ratio vs. SectorThe P/E ratio of Encompass Health is 25.41, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.14.Price to Earnings Growth RatioEncompass Health has a PEG Ratio of 2.31. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioEncompass Health has a P/B Ratio of 4.09. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.19% of the float of Encompass Health has been sold short.Short Interest Ratio / Days to CoverEncompass Health has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Encompass Health has recently increased by 4.81%, indicating that investor sentiment is decreasing. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldEncompass Health has a dividend yield of 0.69%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthEncompass Health does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Encompass Health is 15.25%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Encompass Health will have a dividend payout ratio of 12.88% next year. This indicates that Encompass Health will be able to sustain or increase its dividend.Read more about Encompass Health's dividend. Sustainability and ESG5.0 / 5Environmental Score-0.71 Percentage of Shares Shorted2.19% of the float of Encompass Health has been sold short.Short Interest Ratio / Days to CoverEncompass Health has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Encompass Health has recently increased by 4.81%, indicating that investor sentiment is decreasing. News and Social Media2.8 / 5News Sentiment1.08 News SentimentEncompass Health has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 27 news articles for Encompass Health this week, compared to 8 articles on an average week.Search InterestOnly 3 people have searched for EHC on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Encompass Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -43% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Encompass Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $495,578.00 in company stock.Percentage Held by InsidersOnly 2.10% of the stock of Encompass Health is held by insiders.Percentage Held by Institutions97.25% of the stock of Encompass Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Encompass Health's insider trading history. Receive EHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter. Email Address EHC Stock News HeadlinesEncompass Health Corporation (EHC) Q1 2025 Earnings Call TranscriptApril 26 at 12:03 AM | seekingalpha.comEncompass Health price target raised to $122 from $120 at KeyBancApril 25 at 2:40 PM | markets.businessinsider.comTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you ready for it?April 26, 2025 | Porter & Company (Ad)Encompass Health names Patrick Tuer as COO, effective immediatelyApril 25 at 4:39 AM | markets.businessinsider.comEncompass Health reports Q1 adjusted EPS $1.37, consensus $1.19April 25 at 4:39 AM | markets.businessinsider.comEncompass Health (NYSE:EHC) Posts Better-Than-Expected Sales In Q1April 24 at 6:37 PM | finance.yahoo.comEncompass Health announces promotion of Patrick Tuer to newly established COO positionApril 24 at 4:24 PM | prnewswire.comEncompass Health reports results for first quarter 2025April 24 at 4:20 PM | prnewswire.comSee More Headlines EHC Stock Analysis - Frequently Asked Questions How have EHC shares performed this year? Encompass Health's stock was trading at $92.35 at the beginning of the year. Since then, EHC shares have increased by 22.7% and is now trading at $113.33. View the best growth stocks for 2025 here. How were Encompass Health's earnings last quarter? Encompass Health Co. (NYSE:EHC) issued its earnings results on Thursday, April, 24th. The company reported $1.37 EPS for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a trailing twelve-month return on equity of 17.56% and a net margin of 8.48%. Read the conference call transcript. Is Encompass Health buying back stock? Encompass Health's board initiated a stock repurchase program on Wednesday, July 24th 2024, which permits the company to repurchase $500,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 5.4% of its stock through open market purchases. Stock buyback programs are often an indication that the company's board of directors believes its shares are undervalued. Does Encompass Health have any subsidiaries? Encompass Health subsidiaries include these companies: Baptist Outpatient Services Inc., Frontier Home Health and Hospice, Generation Solutions of Lynchburg LLC, Alacare Home Health & Hospice, Camellia Healthcare, CareSouth Health System Inc., Reliant Hospital Partners LLC, and others. Who are Encompass Health's major shareholders? Encompass Health's top institutional investors include Copeland Capital Management LLC (1.25%), Sumitomo Mitsui Trust Group Inc. (0.76%), Reinhart Partners LLC. (0.56%) and Fort Washington Investment Advisors Inc. OH (0.30%). Insiders that own company stock include Mark J Tarr, Douglas E Coltharp, John Patrick Darby, Andrew L Price, Elissa Joy Charbonneau, Greg D Carmichael and Kevin J O'connor. View institutional ownership trends. How do I buy shares of Encompass Health? Shares of EHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Encompass Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Encompass Health investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Arista Networks (ANET). Company Calendar Record date for 4/15 Dividend4/01/2025Ex-Dividend for 4/15 Dividend4/01/2025Dividend Payable4/15/2025Last Earnings4/24/2025Today4/25/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Hospitals Sub-IndustryHealth Care Facilities Current SymbolNYSE:EHC CIK785161 Webwww.healthsouth.com Phone(205) 967-7116Fax205-969-4719Employees35,000Year Founded1984Price Target and Rating Average Stock Price Target$110.88 High Stock Price Target$129.00 Low Stock Price Target$95.00 Potential Upside/Downside-2.2%Consensus RatingBuy Rating Score (0-4)3.20 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)$4.46 Trailing P/E Ratio25.41 Forward P/E Ratio23.61 P/E Growth2.31Net Income$455.70 million Net Margins8.48% Pretax Margin13.95% Return on Equity17.56% Return on Assets7.06% Debt Debt-to-Equity Ratio0.84 Current Ratio1.05 Quick Ratio1.04 Sales & Book Value Annual Sales$5.37 billion Price / Sales2.12 Cash Flow$8.58 per share Price / Cash Flow13.21 Book Value$27.72 per share Price / Book4.09Miscellaneous Outstanding Shares100,709,000Free Float98,634,000Market Cap$11.41 billion OptionableOptionable Beta0.87 Social Links A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NYSE:EHC) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Encompass Health Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Encompass Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.